IP Library Assignment 067887/0356
Patent Assignment
Reel/Frame 067887/0356

Assignment of Assignor's Interest

Recorded: 2024-07-01 Pages: 9
Assignor
BLUEPRINT MEDICINES CORPORATION
Executed: 2024-02-22
Assignee
RIGEL PHARMACEUTICALS, INC.
611 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Ret Inhibitor for Use in Treating Cancer Having a Ret Alteration
Application: 18/606,346 →
Publication: US 2025/0041297
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 1, 2024
From: EVANS RAAB, ERICA
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 067887/0347 →
Assignment of Assignor's Interest Jul 1, 2024
From: WOLF, BENI B.,
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 067887/0351 →
Security Interest May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →